精神兴奋剂使用背后的神经生物学机制
Rianne R Campbell1, Mary Kay Lobo2
1Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: https://twitter.com/RianneThoughts.
Current opinion in neurobiology
|September 30, 2023
概括
精神兴奋剂使用障碍 (PSUD) 的发病率正在上升,但目前还没有药物可以帮助戒断. 本综述探讨了神经生物学机制,包括转录和突触可塑性,这对于开发新的PSUD药物疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 精神兴奋剂使用障碍 (PSUD) 是一个日益严重的公共卫生问题,没有批准的药物治疗方法.
- 慢性精神兴奋剂的使用会改变与决策,奖励和记忆有关的大脑功能,导致强迫性寻找药物的行为.
研究的目的:
- 审查关于PSUD神经生物学基础的新发现和理论.
- 确定有前途的分子和神经电路机制,用于开发用于PSUD的新药疗法.
主要方法:
- 本综述综合了当前关于精神兴奋剂对大脑机制影响的研究.
- 专注于分子通路 (转录,线粒体功能) 和神经电路 (突触可塑性,网络重新布线).
主要成果:
- 精神兴奋剂在奖励系统中失调转录,线粒体功能和突触可塑性.
- 这些变化通过重新连接神经网络来促进持续的渴望和寻找药物的行为.
- 有证据表明,特定的分子和电路水平的变化驱动了与成有关的行为.
结论:
- 了解PSUD的神经生物学,特别是在分子和突触层面,是药物治疗发展的关键.
- 针对转录,线粒体功能和突触可塑性等机制,为新的PSUD治疗提供了有希望的途径.
- 对这些生物基的进一步研究对于推进成药物治疗至关重要.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
224
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
224
Stimulants
237
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
237
Drug Abuse and Addiction: Pharmacological Phenomena
501
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
501
Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Attention-Deficit/Hyperactivity Disorder
85
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
85


